Discussion We report a large-scale GWAS of treatment response to GLP1 medications and identify a missense variant in GLP1R , which encodes the therapeutic target of semaglutide and tirzepatide that associates with BMI loss
(PubMed) Kuiper C, Molenaar IG, Dachs GU, Currie MJ, Sykes PH, Vissers MC
Growth hormone deficiency, thyroid dysfunction, and cortisol dysregulation are common after stroke and each independently impairs neuroplasticity
AnnualSave 47% Discounted annual rate Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Monthly Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Ad-Free Premium ad-free reading Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Already have an account
Although the exact mechanism of depigmenting potential of cysteamine is unclear, however, it has been reported that melanocytotoxicity is not involved (Qiu et al., 2000
Prineas, 1975
